The Global Bioresorbable Surgical Material Market was valued at USD 1.82 Billion in 2024 and is projected to reach USD 3.45 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 11.2% during the forecast period (2024–2030). This rapid expansion is driven by increasing orthopedic procedures, advancements in polymer science, and the demand for minimally invasive surgical solutions that eliminate secondary removal surgeries.

As healthcare moves toward materials that safely dissolve in the body, key players are developing innovative polymer formulations for superior clinical outcomes. This analysis profiles the Top 10 Companies in the Bioresorbable Surgical Material Market – materials science innovators and medical device manufacturers transforming surgical care through absorption-controlled technologies.

---

🔟 1. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: RESOMER® bioresorbable polymers (PLA, PGA, PCL)

Evonik leads the market with its RESOMER polymer platform serving as the foundation for absorbable sutures, orthopedic fixtures, and drug-eluting implants. Their FDA-approved materials offer precise degradation rates matched to clinical requirements.

Platform Advantages:

• RESOMER Select – customizable degradation from 3 weeks to 5 years
• Serves 85% of leading medical device manufacturers
• EUR 250 million annual investment in biomaterials R&D

Download FREE Sample Report:
Global Bioresorbable Surgical Material Market – View in Detailed Research Report

---

9️⃣ 2. Corbion N.V.

Headquarters: Amsterdam, Netherlands
Key Offering: Purasorb® PLA/PGA copolymers

Corbion’s high-purity lactide/glycolide polymers support over 200 certified medical devices, with production capacity exceeding 50,000 metric tons annually for orthopedic and cardiovascular applications.

Material Innovations:

• Patented purification process reduces residual monomers
• 40% market share in European absorbable polymer supply
• GMP+ certified manufacturing facilities

---

8️⃣ 3. DSM Biomedical

Headquarters: Heerlen, Netherlands
Key Offering: Dyneema Purity® bioresorbable fibers

DSM’s surgical-grade UHMWPE fibers enable next-generation absorbable meshes and reinforcement matrices with superior strength-to-weight ratios and controlled resorption profiles.

Clinical Breakthroughs:

• First commercially viable bioresorbable hernia mesh (2022)
• FDA-cleared for cardiovascular patch applications
• 25% faster tissue ingrowth vs conventional materials

---

7️⃣ 4. Mitsui Chemicals, Inc.

Headquarters: Tokyo, Japan
Key Offering: LACTEL® absorbable polymer systems

Mitsui Chemicals dominates Asian markets with its LACTEL polymers used in 60+ FDA-cleared devices, particularly orthopedic fixation products requiring precise absorption timing.

Regional Leadership:

• Supplies 70% of Japan’s bioresorbable implant materials
• New USD 85 million Singapore production facility (2024)
• Proprietary chain extension technology enhances material properties

Download FREE Sample Report:
Global Bioresorbable Surgical Material Market – View in Detailed Research Report

---

6️⃣ 5. Poly-Med, Inc.

Headquarters: Anderson, SC, USA
Key Offering: Custom bioresorbable formulations

This specialty manufacturer provides engineered polymer solutions for niche applications including pediatric devices, tissue scaffolds, and combination products with growth factors.

Unique Capabilities:

• Over 350 material formulations in portfolio
• ISO 13485 certified small-batch production
• 12-18 month formulation-to-FDA clearance pipeline

---

5️⃣ 6. KLS Martin Group

Headquarters: Tuttlingen, Germany
Key Offering: RESORX® fixation systems

KLS Martin specializes in craniomaxillofacial implants using proprietary copolymer blends that maintain mechanical integrity during critical bone healing phases.

Surgical Solutions:

• 94% adoption rate in pediatric cranial reconstruction
• CE Mark for craniofacial trauma plates
• 30% lower inflammation markers vs PLLA standards

---

4️⃣ 7. Medtronic plc

Headquarters: Dublin, Ireland
Key Offering: VICRYL® Plus antimicrobial sutures

Medtronic’s surgical solutions division leverages its VICRYL polymer platform in suture products accounting for 35% of the global absorbable suture market.

Product Evolution:

• Triclosan coating reduces SSI risk by 28%
• Absorption profile matched to wound healing phases
• Robotic surgery optimized variants introduced in 2023

---

3️⃣ 8. Johnson & Johnson (Ethicon)

Headquarters: New Brunswick, NJ, USA
Key Offering: PDS® II and MONOCRYL® sutures

J&J’s Ethicon division continues to advance absorbable suture technology while expanding into bioresorbable meshes for hernia and soft tissue repair applications.

Innovation Pipeline:

• STRATAFIX™ knotless tissue control devices
• PEG-based sealant in Phase III trials
• Absorption-tuned polymers for robotic surgery

---

2️⃣ 9. Smith & Nephew plc

Headquarters: London, UK
Key Offering: REGENESORB™ fixation systems

Smith & Nephew’s sports medicine division utilizes bioresorbable composites in interference screws and suture anchors designed for ligament reconstruction procedures.

Orthopedic Expertise:

• Variable absorption rate technology
• Partnerships with 12 professional sports organizations
• 95% surgeon satisfaction in ACL reconstruction

---

1️⃣ 10. Zimmer Biomet Holdings, Inc.

Headquarters: Warsaw, IN, USA
Key Offering: OSSEOSPEED™ resorbable membrane

Zimmer Biomet pioneers dental and craniofacial regeneration solutions with its resorbable collagen-PGA membranes demonstrating superior bone integration properties.

Clinical Validation:

• 98.2% successful alveolar ridge preservation
• 3D-printed patient-specific scaffolds
• Combination products with BMP growth factors

Get Full Report Here:
Global Bioresorbable Surgical Material Market – View in Detailed Research Report

---

⚕️ Outlook: The Future of Bioresorbable Surgical Materials

The bioresorbable materials sector is entering an accelerated innovation phase, with advanced polymers enabling breakthrough applications across surgical specialties.

🔬 Key Market Evolution Drivers:

• FDA expedited pathways for novel biomaterials (5 approvals in 2023)
• 45% growth in minimally invasive procedure adoption
• Convergence with 3D printing for patient-specific implants
• Smart materials with drug-eluting capabilities
• Expansion into neurology and cardiology applications

Get Full Report Here:
Global Bioresorbable Surgical Material Market – View in Detailed Research Report

These industry leaders are not just supplying materials—they’re redefining surgical standards through biomaterial innovations that improve patient outcomes and reduce healthcare burdens.